Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Melanoma 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
2 Melanoma 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
3 Melanoma 💬
 3件: BRAF, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
4 Melanoma 💬
 3件: BRAF, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
5 Melanoma 💬
 2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
6 Melanoma 💬
 1件: EGFR 💬 Afatinib 💬 Afatinib 1件: 285 💬
7 Melanoma 💬
 1件: EGFR 💬 Afatinib dimaleate 💬 Afatinib 1件: 285 💬
8 Melanoma 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
9 Melanoma 💬
 1件: EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib 2件: 94, 160 💬
10 Melanoma 💬
 1件: EGFR 💬 Erlotinib 💬 Erlotinib 2件: 94, 160 💬
11 Melanoma 💬
 1件: EGFR 💬 Gefitinib 💬 Gefitinib 1件: 75 💬
12 Melanoma 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
13 Melanoma 💬
 1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
14 Melanoma 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
15 Melanoma 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
16 Melanoma 💬
 1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
17 Melanoma 💬
 1件: EGFR 💬 Tesevatinib 💬 Tesevatinib 1件: 67 💬
18 Melanoma 💬
 1件: FGF19 💬 Aldafermin 💬 Aldafermin 1件: 94 💬
19 Melanoma 💬
 1件: FGF23 💬 Burosumab 💬 Burosumab 1件: 238 💬
20 Melanoma 💬
 1件: FGFR1 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
21 Melanoma 💬
 1件: FGFR1 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
22 Melanoma 💬
 3件: FGFR1, PDGFRA, PDGFRB 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
23 Melanoma 💬
 3件: FGFR1, PDGFRA, PDGFRB 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
24 Melanoma 💬
 3件: FGFR1, PDGFRA, PDGFRB 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
25 Melanoma 💬
 1件: IGF1R 💬 Linsitinib 💬 Linsitinib 1件: 232 💬
26 Melanoma 💬
 1件: IGF1R 💬 Mecasermin 💬 Mecasermin 4件: 96, 168, 265, 299 💬
27 Melanoma 💬
 1件: IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin 4件: 96, 168, 265, 299 💬
28 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
29 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 Cobimetinib 💬 Cobimetinib 1件: 280 💬
30 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 Cobimetinib fumarate 💬 Cobimetinib 1件: 280 💬
31 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
32 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
33 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
34 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
35 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
36 Melanoma 💬
 1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
37 Melanoma 💬
 1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
38 Melanoma 💬
 1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
39 Melanoma 💬
 1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
40 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
41 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib 1件: 227 💬
42 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 Seralutinib 💬 Seralutinib 1件: 86 💬
43 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
44 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
45 Melanoma 💬
 1件: PDGFRB 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
46 Melanoma 💬
 1件: PDGFRB 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
47 Melanoma 💬
 1件: PIK3CA_B_D 💬 Alpelisib 💬 Alpelisib 4件: 138, 278, 279, 280 💬
48 Melanoma 💬
 1件: PIK3CA_B_D 💬 Leniolisib phosphate 💬 Leniolisib 2件: 53, 65 💬
49 Melanoma 💬
 1件: PIK3CA_B_D 💬 Parsaclisib 💬 Parsaclisib 3件: 35, 53, 61 💬
50 Melanoma 💬
 2件: PIK3CA_B_D, PIK3CA_B_D 💬 Copanlisib 💬 Copanlisib 1件: 121 💬
51 Melanoma 💬
 3件: PIK3CA_B_D, PIK3CA_B_D, PIK3CA_B_D 💬 Leniolisib 💬 Leniolisib 2件: 53, 65 💬